| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in LQDA over the last quarter tilts toward selling: insiders offloaded a net 389,884 shares worth roughly $27.8M. In the past 30 days, 0 insiders bought and 9 sold.
On the other side, 9 insiders reduced their position over the period. LQDA sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.13M | $740.41M | - | |
| CEO | 1.16M | $105.88M | -35,249 | |
| Dir | 701.5K | $63.86M | -78,596 | |
| Other | 606.0K | $55.16M | -14,738 | |
| Dir | 469.6K | $42.75M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 18, 2022 | Manning Paul B54 | Director | Buy | 392,156 | $5.10 | $1,999,995.60 | New | -27.4% | +35.8% | |
| Apr 18, 2022 | Caligan Partners LP58 | Director, 10% Owner, See Remarks | Buy | 1,764,705 | $5.10 | $8,999,995.50 | +21.2% | -27.4% | +35.8% | |
| Nov 10, 2021 | Schundler Russell57 | General Counsel | Buy | 117,908 | $4.21 | $496,834.09 | +30.7% | +56.3% | +15.6% | |
| Nov 10, 2021 | Kirsch Arthur S | Director | Buy | 30,000 | $4.24 | $127,200.00 | +1,500% | +56.3% | +15.6% | |
| May 18, 2021 | Schundler Russell57 | General Counsel | Buy | 97,755 | $2.77 | $270,817.83 | +121.5% | -4.7% | +104.7% | |
| Apr 13, 2021 | Manning Paul B54 | Director, 10% Owner | Buy | 198,413 | $2.52 | $500,000.76 | +36.8% | +3.9% | +105.1% | |
| Apr 13, 2021 | Jeffs Roger64 | Director | Buy | 99,206 | $2.52 | $249,999.12 | +793.6% | +3.9% | +105.1% | |
| Jan 26, 2021 | Eshelman Ventures, LLC | 10% Owner | Sell | 1,762,162 | $3.12 | $5,502,527.06 | -40.4% | - | - | |
| Jan 25, 2021 | Eshelman Ventures, LLC | 10% Owner | Sell | 1,219,287 | $2.96 | $3,612,315.68 | -11.4% | - | - | |
| Jan 21, 2021 | Eshelman Ventures, LLC | 10% Owner | Sell | 328,250 | $2.96 | $972,079.55 | -5.6% | - | - |